Gait Parameters and Balance in Patients With Obstructive Lung Diseases
Investigation of Gait Parameters and Balance in Patients With Obstructive Lung Diseases
1 other identifier
observational
30
1 country
1
Brief Summary
In the literature, most of the studies examining the gait characteristics and balance separately or examining the relationship between them are on patients with COPD. No study examining gait parameters in other obstructive pulmonary patients such as bronchiectasis and asthma was found.A convincing link between gait disturbances and falls in COPD patients is still unknown and further research is needed. Therefore, the purpose of our study; gait parameters and balance in individuals with obstructive pulmonary disease. We will also examine the relationship between gait parameters and extrapulmonary clinical indicators of these individuals.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for all trials
Started Jul 2019
Longer than P75 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
July 17, 2019
CompletedFirst Submitted
Initial submission to the registry
August 15, 2019
CompletedFirst Posted
Study publicly available on registry
August 20, 2019
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 1, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
December 1, 2024
CompletedAugust 30, 2024
August 1, 2024
5.4 years
August 15, 2019
August 29, 2024
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Gait parameters
Gait parameters will be assessed with Biodex Gait Trainer (Biodex Medical Systems, Shirley, New York) for six minutes.
01.09.2020-08.07.2021
Secondary Outcomes (5)
Functional Balance and Fall Risk
01.09.2020-08.07.2021
Functional Exercise Capacity
01.09.2020-08.07.2021
Respiratory Muscle Strength
01.09.2020-08.07.2021
Peripheral Muscle Strength
01.09.2020-08.07.2021
Cognitive Status
01.09.2020-08.07.2021
Study Arms (2)
Obstructive lung diseases group
1. Having been diagnosed with obstructive pulmonary disease, 2. No acute exacerbation or infection in the past 1 week, Being between the ages of 18 and 65,
Healthy group
Age and sex matched healthy subjects without orthopedic and chronic diseases
Eligibility Criteria
The obstructive lung diseases from every subgroups: COPD, asthma and bronchiectasis patients
You may qualify if:
- Being diagnosed with obstructive lung disease,
- Have not experienced acute exacerbation or infection in the last 1 week,
- To be between 18-65 years,
- Volunteering for research,
- To be able to walk and cooperate.
You may not qualify if:
- Use walking aid or be chronic oxygen support
- To have orthopedic or neuromuscular comorbidities that may affect walking patterns.
- Having had lung cancer, sarcoidosis, tuberculosis disease or lung surgery.
- Having any cardiopulmonary disease,
- To have an advanced orthopedic disease that may affect functional capacity measurement and gait patterns.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Naciye Vardar-Yagli
Ankara, 06100, Turkey (Türkiye)
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Naciye Vardar-Yagli, PhD
Hacettepe University
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- CASE CONTROL
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Associate Professor
Study Record Dates
First Submitted
August 15, 2019
First Posted
August 20, 2019
Study Start
July 17, 2019
Primary Completion
December 1, 2024
Study Completion
December 1, 2024
Last Updated
August 30, 2024
Record last verified: 2024-08
Data Sharing
- IPD Sharing
- Will not share